-transparent.png){kind=logo}
The therapeutic efficacy of brofaromine--a new reversible and short acting MAO-A inhibitor--was evaluated in 14 inpatients with a panic disorder. In an open trial, the patients were treated with placebo during the first week and with 150 mg brofaromine per day during the following four weeks. In all patients a distinct improvement in both anxiety and depressive symptoms was observed under the active drug. Treatment outcome was the same in patients with and without a concomitant major depressive episode. No side-effects of any note were reported. Our findings suggest that the MAO-A inhibitor brofaromine is an effective drug in the treatment of anxiety disorders.
Related Publications
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
February 1994,
Journal of clinical psychopharmacology,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
August 1993,
Journal of clinical psychopharmacology,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 1993,
Clinical neuropharmacology,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 1993,
Clinical neuropharmacology,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 1989,
Journal of neural transmission. Supplementum,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 1992,
Clinical neuropharmacology,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
March 1993,
Biological psychiatry,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 1996,
Journal of enzyme inhibition,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
January 2016,
Central nervous system agents in medicinal chemistry,
D Garcia-Borreguero, and
C J Lauer, and
A Ozdaglar, and
K Wiedemann, and
F Holsboer, and
J C Krieg
December 1993,
Journal of sleep research,
